Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 755

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 755
---
 | ​ |                         |           | ​ |   |           | ​ |   |           |
| Change in unrealized gains (losses) on available-for-sale marketable securities            | ​ |                         |     1,412 | ​ |   |    -1,314 | ​ |   |      -431 |
| Total comprehensive loss                                                                   | ​ | $                       |  -117,101 | ​ | $ |   -86,788 | ​ | $ |   -88,872 |

See Notes to Consolidated Financial Statements.

F-37

CARA THERAPEUTICS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (amounts in thousands, except share and per share data)

| ​                                                                                         
 ​                                                                                         
 ​                                                                                         
 ​                                                                                         
 ​                                                                                         | ​ 
 ​ 
 ​ 
 ​ |            ​ 
            ​ 
            ​ 
 Common Stock 
       Shares | ​ 
 ​ 
 ​ | ​      
 ​      
 ​      
 Amount | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | ​          
 ​          
 Additional 
 Paid-In    
 Capital    |       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​           
 ​           
 ​           
 Accumulated 
 Deficit     |        ​ 
        ​ 
        ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 Accumulated   
 Other         
 Comprehensive 
 Income (Loss) |      ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 ​             
 Total         
 Stockholders’ 
 Equity        |        ​ 
        ​ |
|:------------------------------------------------------------------------------------------|:--|-------------:|:--|:-------|--:|:--|:-----------|--------:|:--|:------------|---------:|:--|:--------------|-------:|:--|:--------------|---------:|
| Balance at December 31, 2020                                                              | ​ |    4,156,017 | ​ | $      | 4 | ​ | $          | 641,241 | ​ | $           | -392,317 | ​ | $             |     73 | ​ | $             |  249,001 |
| Sale of common stock under license agreement with Vifor International ($182.76 per share) | ​ |      273,533 | ​ | ​      | — | ​ | ​          |  44,966 | ​ | ​           |        — | ​ | ​             |      — | ​ | ​